Yavatmal, India

Sachin Deorao Zade


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Sachin Deorao Zade: A Pioneer in Cancer Treatment Innovations

Introduction

Sachin Deorao Zade is an innovative inventor based in Yavatmal, India. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work exemplifies the intersection of science and technology, showcasing the potential of innovative solutions in healthcare.

Latest Patents

Sachin Zade holds a patent for a novel compound known as Sorafenib dimethyl sulphoxide solvate. This invention provides a dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpyridine-2-carboxamide. The patent outlines the process for its preparation, pharmaceutical composition comprising it, and its use for the treatment of cancer. Additionally, it introduces a novel HPLC method for the identification, quantification, and isolation of related substances of sorafenib.

Career Highlights

Sachin Zade is currently associated with Ranbaxy Laboratories, Inc., where he continues to advance his research and development efforts. His work at this esteemed organization has allowed him to contribute to significant pharmaceutical innovations.

Collaborations

Sachin has collaborated with notable colleagues, including Jagdev Singh Jaryal and Swargam Sathyanarayana. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical field.

Conclusion

Sachin Deorao Zade's contributions to cancer treatment through his innovative patent demonstrate the vital role of inventors in advancing healthcare solutions. His work not only reflects his expertise but also highlights the importance of collaboration in the pursuit of scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…